Anti-IRAK4 Polyclonal Antibody
- 發(fā)布日期： 2019-05-13
- 更新日期： 2025-07-09
產(chǎn)品詳請(qǐng)
| 產(chǎn)地 |
北京
|
| 品牌 |
Solarbio
|
| 保存條件 |
Store at -20°C. Avoid freeze / thaw cycles.
|
| 貨號(hào) |
K106734P
|
| 應(yīng)用范圍 |
WB IHC
|
| CAS編號(hào) |
|
| 抗體名 |
Anti-IRAK4 Polyclonal Antibody
|
| 克隆性 |
Polyclonal Antibody
|
| 靶點(diǎn) |
|
| 適應(yīng)物種 |
Human
|
| 形態(tài) |
|
| 宿主 |
Rabbit
|
| 亞型 |
IgG
|
| 標(biāo)識(shí)物 |
IRAK-4;Renal carcinoma antigen NY-REN-64;Interleukin-1 receptor-associated kinase 4
|
| 濃度 |
%
|
| 免疫原 |
A synthetic peptide of human IRAK4
|
Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1.
